02/01/12 - Sophia-Antipolis, France

MEDIAN signe un contrat majeur avec Sanofi

MEDIAN Technologies signe un contrat majeur avec le laboratoire SANOFI pour l’interprétation et la gestion des images dans une nouvelle étude de phase II sur le cancer du poumon à petites cellules.

 
More info >  (413.2 Kb, PDF File)

02/01/12 - Sophia-Antipolis, France

MEDIAN has signed a landmark contract with Sanofi

MEDIAN Technologies has signed a landmark contract with the top pharmaceutical company SANOFI for medical image interpretation and management in a new phase II study on small cells lung cancer.

 
More info >  (408.8 Kb, PDF File)
 

Testimonials

< Back to Testimonial List
Pr. Olivier Lucidarme
La Pitié-Salpêtrière Hospital - Paris, France
Olivier Lucidarme, MD, is specialist in abdominal imaging at La Pitié-Salpêtrière hospital, Paris, France. He has been using LMS-Liver for a year for the oncological follow-up of liver metastases and HCC in patients under treatment.

“Identifying and measuring the most representative target lesions for the initial evaluation of liver metastases is not an easy task because here may be a lot of lesions to choose from, and it is often difficult to draw their boundaries precisely,” explains Dr. Lucidarme. “When it comes to follow-up, the main problem is the time spent to find in the current exam each lesion identified in the previous; this can be very long.”

LMS-Liver has been designed to help the radiologists answer these difficulties by providing 3D segmentation and automatic measurement of liver lesions. The application also allows to record nodal or other extra-hepatic lesions. All lesions can then be followed very easily thanks to accurate image registration and automatic lesion pairing and growth calculation, and their evolution reported according to RECIST criteria.

Dr. Lucidarme is convinced of the positive impact of LMS-Liver on the daily workflow and productivity. “Using the application allows to gain a lot of time both for the initial evaluation as the identified lesions are segmented and measured automatically, and for the follow-up since one simply has to click on a lesion in the previous exam and the application instantaneously displays the corresponding area in the current. Using LMS-Liver makes comparison studies less tedious for radiologists and ensures the oncologists and patients that such studies are carried out properly.”

The performances of LMS-Liver in terms of follow-up were assessed in a clinical study involving Dr. Lucidarme. The study showed that the image registration was correct in 82 % of the cases, and the automatic pairing in 98 % of the cases. “We concluded that LMS-Liver is an effective tool to locate and pair focal liver lesions during follow-up CT examinations,” says Dr. Lucidarme.